Journal article

Abnormal plasma DNA profiles in early ovarian cancer using a non-invasive prenatal testing platform: implications for cancer screening

Paul A Cohen, Nicola Flowers, Stephen Tong, Natalie Hannan, Mark D Pertile, Lisa Hui

BMC MEDICINE | BIOMED CENTRAL LTD | Published : 2016

DOI: 10.1186/s12916-016-0667-6

University of Melbourne Researchers

Mark Pertile Author Paediatrics Royal Children's Hospital

Stephen Tong Author Obstetrics and Gynaecology Royal Women's Hospital/Mercy

Natalie Hannan Author Obstetrics and Gynaecology Royal Women's Hospital/Mercy

Lisa Hui Author Obstetrics and Gynaecology Royal Women's Hospital/Mercy

Related Projects (2)

Noninvasive prenatal Testing (NIPT) to detect Early stage Ovarian cancer (the NEO study)

TRANSLATING ADVANCES IN CELL-FREE FETAL NUCLEIC ACIDS INTO BETTER PERINATAL CARE

My overall aim is to translate advances in biotechnology into better care for pregnant women. My first aim is to study brain development by ..

Grants

Funding Acknowledgements

Funding for this study was provided by the Norman Beischer Medical Research Foundation.

Citation metrics

27Web of Science

Keywords

Dna Copy Number Variations

Reproducibility of Results

High-Grade Serous Carcinoma

Chromosome Aberrations

General & Internal Medicine

Uk Collaborative Trial

High Grade Serous Carcinoma

Copy Number Variations

Non-Invasive Prenatal Testing

Case-Control Studies

Early Detection of Cancer

Science & Technology

Circulating Tumor Dna

Low Coverage Sequencing

Ovarian Neoplasms

Medicine, General & Internal

Sensitivity and Specificity

Neoplasm Staging

Ovarian Cancer Screening

High-Throughput Nucleotide Sequencing

Prenatal Diagnosis

Life Sciences & Biomedicine

Noninvasive Prenatal Testing

Cytogenetic Analysis

Genomic Profiling